Menu
Menu
\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nLobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nAnother complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nManufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nNovo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nThe FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nAccording to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nAccommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nTrump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nHe went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nIt goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nhe stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\n\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nWhile stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nUS President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nDespite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nAlthough the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nMultnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nThe board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nSince they are independently elected and do not report to the board, the sheriff, district attorney, and auditor will not be governed by the rules, Singleton stated. A $200,000 allocation from the county's general fund contingency account to support an online lobbying registration and calendar reporting system was also approved by the commissioners. According to authorities, the contingency fund, which was used to cover additional security expenses last month, will have $666,917 left over.<\/p>\n\n\n\n
The board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nIn accordance with Brim-Edwards and Singleton's rule, lobbyists must register and submit a quarterly report detailing their attempts to influence policy and any gifts over $50. Commissioners, department heads, staff members, and volunteers would all be subject to such regulations. Commissioners are required to publish their calendars on a quarterly basis.<\/p>\n\n\n\n
Since they are independently elected and do not report to the board, the sheriff, district attorney, and auditor will not be governed by the rules, Singleton stated. A $200,000 allocation from the county's general fund contingency account to support an online lobbying registration and calendar reporting system was also approved by the commissioners. According to authorities, the contingency fund, which was used to cover additional security expenses last month, will have $666,917 left over.<\/p>\n\n\n\n
The board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nCommissioner Shannon Singleton, who co-sponsored the effort with Commissioner Julia Brim-Edwards, stated, \"This is a really big step for this commission.\" The new county policies are modeled after those of the state, Portland, and the Metro regional government. But according to The Oregonian\/OregonLive, neither Clackamas nor Washington counties keep tabs on lobbyists' meetings or expenditures on visits with public officials.<\/p>\n\n\n\n
In accordance with Brim-Edwards and Singleton's rule, lobbyists must register and submit a quarterly report detailing their attempts to influence policy and any gifts over $50. Commissioners, department heads, staff members, and volunteers would all be subject to such regulations. Commissioners are required to publish their calendars on a quarterly basis.<\/p>\n\n\n\n
Since they are independently elected and do not report to the board, the sheriff, district attorney, and auditor will not be governed by the rules, Singleton stated. A $200,000 allocation from the county's general fund contingency account to support an online lobbying registration and calendar reporting system was also approved by the commissioners. According to authorities, the contingency fund, which was used to cover additional security expenses last month, will have $666,917 left over.<\/p>\n\n\n\n
The board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nSignificant modifications to the county's lobbying <\/a>regulations were adopted by the Multnomah County Board of Commissioners. In other words, they will be possessed by the government. The new regulations, which compel entities that lobby the county to report their efforts, were unanimously adopted by the board. Willamette Week was the first to uncover that the county had long functioned without keeping track of its lobbyists. Officials warned that violators of the new rule might face fines of up to $500.<\/p>\n\n\n\n
Commissioner Shannon Singleton, who co-sponsored the effort with Commissioner Julia Brim-Edwards, stated, \"This is a really big step for this commission.\" The new county policies are modeled after those of the state, Portland, and the Metro regional government. But according to The Oregonian\/OregonLive, neither Clackamas nor Washington counties keep tabs on lobbyists' meetings or expenditures on visits with public officials.<\/p>\n\n\n\n
In accordance with Brim-Edwards and Singleton's rule, lobbyists must register and submit a quarterly report detailing their attempts to influence policy and any gifts over $50. Commissioners, department heads, staff members, and volunteers would all be subject to such regulations. Commissioners are required to publish their calendars on a quarterly basis.<\/p>\n\n\n\n
Since they are independently elected and do not report to the board, the sheriff, district attorney, and auditor will not be governed by the rules, Singleton stated. A $200,000 allocation from the county's general fund contingency account to support an online lobbying registration and calendar reporting system was also approved by the commissioners. According to authorities, the contingency fund, which was used to cover additional security expenses last month, will have $666,917 left over.<\/p>\n\n\n\n
The board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n
Manufacturers of compounds (compounders) were legally<\/a> allowed to use chemicals from FDA-approved manufacturers when the FDA notified shortages of Wegovy in March 2022 and for Wegovy and Ozempic in August 2022. With the shortage now declared to be over, unauthorized versions have been banned, though the FDA has granted additional time for compounders to scale back operations and customers to switch treatments.<\/p>\n\n\n\n
Another complication for the firms and their lobbyists is that Robert F Kennedy Jr, the Health and Human Services Secretary has previously voiced opposition to weight-loss medications. In October, Kennedy responded to a study indicating that Ozempic could potentially aid in treating issues such as drug addiction, sleep apnea, and cognitive decline. The newly appointed health secretary asserted that pharmaceutical companies were attempting to market the drug to Americans \u201cbecause we\u2019re so stupid and so addicted to drugs.\u201d<\/p>\n\n\n\n
Lobbyists are making an effort to modify their proposals appropriately. Shawn O'Neail, an Eli Lilly in-house lobbyist, told Politico that while medication isn't always the solution, lifestyle and food alone might often be insufficient to prevent or treat chronic conditions like obesity. <\/p>\n\n\n\n
\n\"That's where medicine can help, as part of a comprehensive strategy to treat chronic illness.\"<\/p>\n<\/blockquote>\n\n\n\n
The Independent represents a lot of things, frequently in a unique way. It makes its own decisions on current topics and remains impartial toward political parties. Debate and challenge have always been important to The Independent. In order to provide a fresh voice, it was founded in 1986. Since then, it has supported causes ranging from the Final Say Brexit petition to the legalization of marijuana.<\/p>\n","post_title":"Weight-loss drug giant boosts D.C. lobbying to over $3M amid regulatory pressure","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"weight-loss-drug-giant-boosts-d-c-lobbying-to-over-3m-amid-regulatory-pressure","to_ping":"","pinged":"","post_modified":"2025-04-30 14:19:30","post_modified_gmt":"2025-04-30 14:19:30","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7684","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":9},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\nBills requiring app store owners to confirm users' ages and obtain parental approval for children before enabling them to download applications were being considered<\/a> by at least nine states, according to a February article. Although legislation requiring internet platforms to verify users' ages has been enacted in a number of states, many of these laws have not yet been put into effect due to legal challenges.\u00a0<\/p>\n","post_title":"Meta & Spotify join forces to lobby against Apple & Google\u2019s app store policies","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"meta-spotify-join-forces-to-lobby-against-apple-googles-app-store-policies","to_ping":"","pinged":"","post_modified":"2025-05-04 15:19:07","post_modified_gmt":"2025-05-04 15:19:07","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7699","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7700,"post_author":"7","post_date":"2025-05-04 14:58:43","post_date_gmt":"2025-05-04 14:58:43","post_content":"\n
Significant modifications to the county's lobbying <\/a>regulations were adopted by the Multnomah County Board of Commissioners. In other words, they will be possessed by the government. The new regulations, which compel entities that lobby the county to report their efforts, were unanimously adopted by the board. Willamette Week was the first to uncover that the county had long functioned without keeping track of its lobbyists. Officials warned that violators of the new rule might face fines of up to $500.<\/p>\n\n\n\n
Commissioner Shannon Singleton, who co-sponsored the effort with Commissioner Julia Brim-Edwards, stated, \"This is a really big step for this commission.\" The new county policies are modeled after those of the state, Portland, and the Metro regional government. But according to The Oregonian\/OregonLive, neither Clackamas nor Washington counties keep tabs on lobbyists' meetings or expenditures on visits with public officials.<\/p>\n\n\n\n
In accordance with Brim-Edwards and Singleton's rule, lobbyists must register and submit a quarterly report detailing their attempts to influence policy and any gifts over $50. Commissioners, department heads, staff members, and volunteers would all be subject to such regulations. Commissioners are required to publish their calendars on a quarterly basis.<\/p>\n\n\n\n
Since they are independently elected and do not report to the board, the sheriff, district attorney, and auditor will not be governed by the rules, Singleton stated. A $200,000 allocation from the county's general fund contingency account to support an online lobbying registration and calendar reporting system was also approved by the commissioners. According to authorities, the contingency fund, which was used to cover additional security expenses last month, will have $666,917 left over.<\/p>\n\n\n\n
The board is evaluating a number of governance reforms, including these regulations, many of which Brim-Edwards initially supported last year. According to the ordinance, lobbyists who achieve the county's threshold of 10 lobbying hours every calendar quarter are required<\/a> to register within three business days, such who confine their advocacy to public speech at board meetings, spend fewer than ten hours each quarter lobbying elected officials, or are responding to a board request would not be subject to such regulations. According to the rules, government employees who are \"acting in their official capacity\" are likewise excluded.<\/p>\n\n\n\n
Multnomah County manages libraries, reduces homelessness, addresses public health and safety concerns, and provides other municipal services with billions of dollars. Nonprofit contractors receive a significant portion of its funding, and they frequently persuade commissioners and department heads to gain a piece of the $4 billion government budget.<\/p>\n\n\n\n
Although the legislation takes effect on July 1st, authorities stated that they will gradually implement the new regulations and that it could take some time to set up the reporting system.<\/p>\n","post_title":"Multnomah County adopts first-ever lobbying rules in major transparency push","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"multnomah-county-adopts-first-ever-lobbying-rules-in-major-transparency-push","to_ping":"","pinged":"","post_modified":"2025-05-04 14:58:44","post_modified_gmt":"2025-05-04 14:58:44","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7700","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7691,"post_author":"7","post_date":"2025-04-30 20:42:56","post_date_gmt":"2025-04-30 20:42:56","post_content":"\n
Despite allegations that US President Donald Trump has repeatedly asked Sir Keir Starmer to host golf's oldest major at his Turnberry course in 2028, Downing Street maintains that the choice of Open hosts is up to the organisers.<\/p>\n\n\n\n
US President Donald Trump<\/a> has on several occasions asked UK Prime Minister Sir Keir Starmer to consider staging golf's oldest major, The Open Championship, at his Turnberry resort in Scotland in 2028. These approaches have prompted talks between the R&A (the governing body of the tournament) and UK government ministers, including Whitehall and the Department for Culture, Media and Sport, regarding the practicality of hosting the event at Turnberry<\/p>\n\n\n\n
While stating that it was independent of the government, the prime minister's official spokesperson did not deny that Whitehall officials had contacted the R&A, the organisation that hosts the Open Championship, regarding holding the event at Trump Turnberry.<\/p>\n\n\n\n
\n\"I wouldn't get into specific conversations, but sporting bodies, not the government, should make decisions about tournament venues,\" <\/p>\n<\/blockquote>\n\n\n\n
he stated. <\/p>\n\n\n\n
It goes without saying that the government often communicates with athletic associations regarding competitions, but not in any other way<\/a>.<\/p>\n\n\n\n
He went on to say: <\/p>\n\n\n\n
\n\"It is obviously appropriate and normal for the government to interact with the organisers of major athletic events as part of its business, but the relevant sporting bodies should make decisions regarding tournament hosting locations.\"<\/p>\n<\/blockquote>\n\n\n\n
\n\"I'm not going to go beyond the readouts that you've got on their conversations,\" <\/p>\n<\/blockquote>\n\n\n\n
Trump remarked when asked if he had discussed with the Prime Minister the idea of holding the 2028 tournament at Turnberry, which last hosted the Open in 2009, as reported by the Guardian. However, the main idea is that the appropriate athletic organisations should make the decisions about tournament locations.<\/p>\n\n\n\n
\"We regularly engage with Government and local government regarding venues,\" stated an R&A spokesperson. The government is aware of the situation after we informed them of the logistical difficulties around Turnberry.<\/p>\n\n\n\n
Accommodations and road and rail connections are seen to be the main obstacles to holding the Open in Turnberry. More than twice as many fans\u2014278,000\u2014are expected to attend this year's event at Royal Portrush, which drew 120,000 in 2009.<\/p>\n","post_title":"UK Government rejects claims it lobbied for Trump Turnberry Open bid","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"uk-government-rejects-claims-it-lobbied-for-trump-turnberry-open-bid","to_ping":"","pinged":"","post_modified":"2025-04-30 20:42:58","post_modified_gmt":"2025-04-30 20:42:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7691","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7684,"post_author":"7","post_date":"2025-04-30 14:19:29","post_date_gmt":"2025-04-30 14:19:29","post_content":"\n
According to documents, major pharmaceutical companies have already spent more than $3 million urging the government to crack down on imitation weight-loss medications. Politico claims that Novo Nordisk, the company that makes Ozempic and Wegovy, has engaged a number of lobbying firms to pressure politicians to adopt a tougher stance against businesses manufacturing unapproved copies of the medications.<\/p>\n\n\n\n
The FDA said earlier this year that a years-long scarcity of semaglutide (Ozempic) was over, which led to an increase in illegal and counterfeit forms of the medication. According to the FDA's website, those versions, referred to as compounded medications, \"can be risky for patients, as unapproved versions do not undergo FDA's review for safety, effectiveness, and quality before they are marketed.\"<\/p>\n\n\n\n
Novo Nordisk spent $3 million on lobbying in the first quarter of this year, according to a Politico analysis of lobbying data<\/a>. Eli Lilly, a fellow maker of the weight-loss medications Zepbound and Mounjaro, also spent $3 million on lobbying overall. According to the site, the two businesses enlisted the assistance of over ten lobbying firms, including Avoq, Holland & Knight, and Williams and Jensen.<\/p>\n\n\n\n
\"Novo Nordisk has publicly and openly advocated for changes to our health care system to benefit patients, and as part of those efforts, we participate in advocacy and stakeholder engagements,\" a Novo Nordisk spokeswoman told The Independent in a statement. Our company operations demonstrate our steadfast dedication to moral business behavior and completely conform to applicable laws.<\/p>\n\n\n\n